Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Miss Jane Arnold
+44 (0)114 2220882
j.a.arnold@sheffield.ac.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - A randomised controlled trial of an intervention to improve communication with patients suffering acute chest pain
Back

A randomised controlled trial of an intervention to improve communication with patients suffering acute chest pain

Not Recruiting

Open to: All Genders

Age: Adult

Sheffield

Medical Conditions

Acute chest pain

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Not provided at time of registration

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

15 Nov 2005 14 Nov 2007

Publications

2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19246544 results

Interventional

Intervention Type : Other
Intervention Description : Chest pain from suspected heart disease is a common cause for emergency hospital attendance. Despite receiving a thorough investigation, many patients report anxiety, poor health and concerns regarding poor communication after their hospital attendance. Written factsheets have been shown to improve communication in the outpatient setting. This study will adapt these factsheets to the emergency setting and formally test them. We will give factsheets to some patients, but not others, and then compare levels of anxiety, health, chest pain symptoms, satisfaction with care, and attempts at lifestyle change. If the factsheets are beneficial for patients, we will recommend their widespread use.

During the initial four months of the evaluation fifteen to twenty semi-structured face-to-face interviews will be undertaken with patients who have recently undergone diagnostic assessment on the CPU. Patients assessed on the CPU will be given the factsheet relevent to their condition following diagnostic evaluation and verbal communication with medical and nursing staff. Appropriate individuals will be identified and invited to participate in the study.

The interview will focus on identifying misunderstandings, inappropriate advice, and potential areas for improvement. Following analysis of the transcripts the factsheets will be adapted to take into account feedback from the interviews and ensure that they are appropriate for use in the emergency setting.

Phase 2: Evaluation of the factsheetsThe specific hypotheses outlined in the aims will be tested in a randomised controlled trial. Consecutive patients with acute chest pain who are managed on the CPU will be invited to participate in the trial. Eligible patients will be asked to provide written, informed consent. After providing consent each patient will be randomly allocated to receive either standard verbal advice or verbal advice augmented with the written factsheet.

Follow-up:One month after attendance all participants will be sent a postal questionnaire consisting of the Hospital Anxiety and Depression Scale (HADS), the SF-36 health-related quality of life survey, the Group Health Association of America (GHAA) Consumer Satisfaction Survey, and a brief questionnaire asking:1. Severity and duration of any chest pain related symptoms2. Any attempts at lifestyle change (smoking cessation, dietary change and exercise)3. Specific questions testing the patientÂ’s knowledge of their complaint4. Whether the patient sought information about their complaint from other sources




You can take part if:



You may not be able to take part if:


Patients who are unable to read or understand the trial will be excluded.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • MCRU
    Sheffield
    S1 4DA

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.

Miss Jane Arnold
+44 (0)114 2220882
j.a.arnold@sheffield.ac.uk



The study is sponsored by The University of Sheffield (UK) and funded by The Health Foundation (UK) - Leading practice through research award scheme (ref: 577/3869).



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN85248020
Last updated 03 March 2009

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top